Literature DB >> 20007826

Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization.

Nilanjana Sengupta1, Aqeela Afzal, Sergio Caballero, Kyung-Hee Chang, Lynn C Shaw, Ji-Jing Pang, Vincent C Bond, Imran Bhutto, Takayuki Baba, Gerard A Lutty, Maria B Grant.   

Abstract

PURPOSE: Modulators of angiogenesis typically work in an orchestrated manner. The authors examined the interaction between insulinlike growth factor (IGF)-1, vascular endothelial growth factor (VEGF), and stromal derived factor (SDF)-1 in vivo and in vitro using angiogenesis models.
METHODS: The angiogenic effect of SDF-1, alone or in combination with IGF-1 and VEGF, was assessed in human lung microvascular endothelial cells using capillary tube formation and thymidine incorporation. Immunohistochemical analysis for CD31, SDF-1, and CXCR4 was performed on mouse eyes 2 weeks after the initiation of laser rupture of Bruch's membrane, a choroidal neovascularization (CNV) model. CXCR4 antagonist and CXCR4 blocking antibody were tested on inhibition of CNV lesion size in this model. Real-time PCR was used to determine mRNA levels for SDF-1, VEGF, IGF-1, and their cognate receptors in the retinal pigment epithelium/choroid complex of mice that underwent this CNV model.
RESULTS: IGF-1 and VEGF demonstrated an additive effect on SDF-1-induced in vitro angiogenesis. CXCR4 immunoreactivity was present in both normal and laser-injured mice at the laser burn site and at the ganglion cell layer, the anterior portion of the inner nuclear layer, photoreceptors, and choroidal stroma. SDF-1 was observed in identical locations but was not seen in photoreceptors. mRNA levels for SDF-1, VEGF, and IGF-1 and their receptors were increased after laser injury. CXCR4-neutralizing antibody reduced neovascularization when injected subretinally but not intraperitoneally or intravitreally.
CONCLUSIONS: The potent proangiogenic factors IGF-1 and VEGF both stimulate SDF-1-induced angiogenesis. Local inhibition of CXCR4 is required for an antiangiogenic effect in CNV lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007826      PMCID: PMC2868476          DOI: 10.1167/iovs.09-4137

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

1.  Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors.

Authors:  Cleve O James; Ming-Bo Huang; Mafuz Khan; Minerva Garcia-Barrio; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

2.  Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression.

Authors:  T Koshiba; R Hosotani; Y Miyamoto; J Ida; S Tsuji; S Nakajima; M Kawaguchi; H Kobayashi; R Doi; T Hori; N Fujii; M Imamura
Journal:  Clin Cancer Res       Date:  2000-09       Impact factor: 12.531

3.  Sphingosine 1-phosphate and platelet-derived growth factor (PDGF) act via PDGF beta receptor-sphingosine 1-phosphate receptor complexes in airway smooth muscle cells.

Authors:  Catherine Waters; Balwinder Sambi; Kok-Choi Kong; Dawn Thompson; Stuart M Pitson; Susan Pyne; Nigel J Pyne
Journal:  J Biol Chem       Date:  2002-12-11       Impact factor: 5.157

4.  Involvement of chemokine receptors in breast cancer metastasis.

Authors:  A Müller; B Homey; H Soto; N Ge; D Catron; M E Buchanan; T McClanahan; E Murphy; W Yuan; S N Wagner; J L Barrera; A Mohar; E Verástegui; A Zlotnik
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

5.  A role for chemokine receptor transactivation in growth factor signaling.

Authors:  E Mira; R A Lacalle; M A González; C Gómez-Moutón; J L Abad; A Bernad; C Martínez-A; S Mañes
Journal:  EMBO Rep       Date:  2001-02       Impact factor: 8.807

Review 6.  Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

Authors:  Napoleone Ferrara; Lisa Damico; Naveed Shams; Henry Lowman; Robert Kim
Journal:  Retina       Date:  2006-10       Impact factor: 4.256

7.  Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration.

Authors:  Imran A Bhutto; Sahng Y Kim; D Scott McLeod; Carol Merges; Naomi Fukai; Bjorn R Olsen; Gerard A Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-05       Impact factor: 4.799

8.  The role of adult bone marrow-derived stem cells in choroidal neovascularization.

Authors:  Nilanjana Sengupta; Sergio Caballero; Robert N Mames; Jason M Butler; Edward W Scott; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

9.  The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization.

Authors:  Raquel Lima e Silva; Jikui Shen; Sean F Hackett; Shu Kachi; Hideo Akiyama; Katsuji Kiuchi; Katsutoshi Yokoi; Maria C Hatara; Thomas Lauer; Sadia Aslam; Yuan Yuan Gong; Wei-Hong Xiao; Naw Htee Khu; Catherine Thut; Peter A Campochiaro
Journal:  FASEB J       Date:  2007-05-23       Impact factor: 5.191

10.  The chemokine SDF1/CXCL12 and its receptor CXCR4 regulate mouse germ cell migration and survival.

Authors:  Kathleen A Molyneaux; Hélène Zinszner; Prabhat S Kunwar; Kyle Schaible; Jürg Stebler; Mary Jean Sunshine; William O'Brien; Erez Raz; Dan Littman; Chris Wylie; Ruth Lehmann
Journal:  Development       Date:  2003-09       Impact factor: 6.868

View more
  18 in total

1.  A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization.

Authors:  Rania S Sulaiman; Judith Quigley; Xiaoping Qi; Michael N O'Hare; Maria B Grant; Michael E Boulton; Timothy W Corson
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-10       Impact factor: 2.671

2.  Inhibited experimental corneal neovascularization by neutralizing anti-SDF-1α antibody.

Authors:  Gao-Qin Liu; Pei-Rong Lu; Long-Biao Li; Xue-Guang Zhang
Journal:  Int J Ophthalmol       Date:  2012-02-18       Impact factor: 1.779

Review 3.  Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.

Authors:  Imran Bhutto; Gerard Lutty
Journal:  Mol Aspects Med       Date:  2012-04-21

4.  Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature.

Authors:  Tea Soon Park; Imran Bhutto; Ludovic Zimmerlin; Jeffrey S Huo; Pratik Nagaria; Diana Miller; Abdul Jalil Rufaihah; Connie Talbot; Jack Aguilar; Rhonda Grebe; Carol Merges; Renee Reijo-Pera; Ricardo A Feldman; Feyruz Rassool; John Cooke; Gerard Lutty; Elias T Zambidis
Journal:  Circulation       Date:  2013-10-25       Impact factor: 29.690

5.  Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.

Authors:  Yue Li; Xiuli Liu; Tongrong Zhou; Mark R Kelley; Paul A Edwards; Hua Gao; Xiaoxi Qiao
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-26       Impact factor: 4.799

6.  Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.

Authors:  Vincent Lambert; Julie Lecomte; Sylvain Hansen; Silvia Blacher; Maria-Luz Alvarez Gonzalez; Ingrid Struman; Nor Eddine Sounni; Eric Rozet; Pascal de Tullio; Jean Michel Foidart; Jean-Marie Rakic; Agnès Noel
Journal:  Nat Protoc       Date:  2013-10-17       Impact factor: 13.491

7.  Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization.

Authors:  Gaoqin Liu; Peirong Lu; Longbiao Li; Hui Jin; Xuefei He; Naofumi Mukaida; Xueguang Zhang
Journal:  Mol Vis       Date:  2011-08-10       Impact factor: 2.367

8.  Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye.

Authors:  Hu Huang; Jikui Shen; Stanley A Vinores
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

Review 9.  Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy.

Authors:  Martin J Siemerink; Ingeborg Klaassen; Cornelis J F Van Noorden; Reinier O Schlingemann
Journal:  J Histochem Cytochem       Date:  2012-10-23       Impact factor: 2.479

10.  An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization.

Authors:  Hong Li; Yu-sheng Wang
Journal:  Mol Vis       Date:  2013-05-29       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.